Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-017920
Filing Date
2013-03-27
Accepted
2013-03-27 16:39:35
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v336872_10k.htm 10-K 1110339
2 EX-10.74 v336872_ex10-74.htm EX-10.74 165299
3 EXHIBIT 31.1 v336872_ex31-1.htm EX-31.1 10108
4 EXHIBIT 31.2 v336872_ex31-2.htm EX-31.2 10090
5 EXHIBIT 32.1 v336872_ex32-1.htm EX-32.1 4573
6 GRAPHIC c_logo.jpg GRAPHIC 20105
7 GRAPHIC c_table.jpg GRAPHIC 208458
8 GRAPHIC d_table.jpg GRAPHIC 72828
  Complete submission text file 0001144204-13-017920.txt   7221055

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ptbg-20121231.xml EX-101.INS 991555
10 XBRL TAXONOMY EXTENSION SCHEMA ptbg-20121231.xsd EX-101.SCH 75309
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptbg-20121231_cal.xml EX-101.CAL 46606
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptbg-20121231_def.xml EX-101.DEF 279275
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptbg-20121231_lab.xml EX-101.LAB 495877
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptbg-20121231_pre.xml EX-101.PRE 353214
Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507 304 292-2226
Protea Biosciences Group, Inc. (Filer) CIK: 0001335103 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51474 | Film No.: 13720415
SIC: 2834 Pharmaceutical Preparations